Principal Investigators


Dr. Bruce Perkins MD MPH FRCPC Endocrinologist, Mount Sinai Hospital/University Health Network

Dr. Perkins obtained his MD and Internal Medicine Residency training at the University of Toronto and his Endocrinology subspecialty training at Harvard University and the Joslin Diabetes Center. He completed his Masters of Public Health in Epidemiology at the Harvard School of Public Health. Dr. Perkins joined the Leadership Sinai Centre for Diabetes at Mount Sinai Hospital in 2013. He is a Professor and Clinician-Scientist at the University of Toronto and his research interests include the identification of valid early phenotypes for diabetic nephropathy and neuropathy as well as technologies in diabetes care including the use of insulin pumps and continuous glucose monitoring in clinical trials and clinical practice.


Dr. David Cherney MD PhD FRCPC Nephrologist, University Health Network

Dr. Cherney is a member of the Banting and Best Diabetes Centre at the University of Toronto where he is an Assistant Professor and Clinician-Scientist. His main research interests in type 1 diabetes include the physiology of renal hyperfiltration in diabetic nephropathy and functional gene polymorphisms in humans.


Dr. Vera Bril MD FRCPC Neurologist, University Health Network

Dr. Bril graduated with her MD from the University of Toronto. She joined the University Health Network in 2003. She is the Director of the Division of Neurology at the UHN. She is a Professor of Medicine at the University of Toronto and her clinical and research interests include Diabetic Neuropathy, Myasthenia Gravis, and Inflammatory Demyelinating Polyneuropathies.

Dr. Michael Brent MD Ophthalmologist, University Health Network

Dr. Brent graduated with his MD from McMaster University in 1983. He completed an internship in Internal Medicine at the University of Toronto before completing the Ophthalmology Residency Program in Toronto in 1987. Dr. Brent joined the department of Ophthalmology at the Toronto Western Hospital, University Health Network in 2005. He is an Assistant Professor at the University of Toronto and his main clinical and research interests are in Macular Degeneration and Diabetic Retinopathy.

Dr. Hillary Keenan PhD Research Associate, Joslin Diabetes Center at Harvard University

Dr. Keenan is a research associate at the Joslin Diabetes Center and a co-principal investigator for the Joslin 50-Year Medalist Study, part of the Joslin Medalist Program.

Our Supporters



The JDRF, formerly known as the Juvenile Diabetes Research Foundation, is a global leader in the search for an end to type 1 diabetes through research funding and advocacy. They are committed to improving the lives of every person with type 1 diabetes and to curing the disease. The JDRF supports research projects in three basic areas: cure, treatment, and prevention.

For more information visit:

Mount Sinai Hospital

Located in the heart of the discovery district in Toronto, Mount Sinai Hospital is a state-of-the-art, 472-bed patient care, teaching, and research hospital. The Sinai Health System focuses on three broad organizational goals: 

  • patient and family-centered care 
  • growing its role as an academic health sciences center and teaching hospital, fully affiliated with the University of Toronto
  • enhancing its community health partnerships

For more information visit:

University Health Network

The University Health Network (UHN) is a major landmark in Canada’s healthcare system and a teaching hospital of the University of Toronto. Spanning across all major disciplines, the UHN includes Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Center, and Toronto Rehab. On a mission for exemplary patient care, research, and education, the UHN vision is to achieve global impact.

For more information visit:

Joslin Diabetes Center

The Joslin Diabetes Center is a teaching and research affiliate of Harvard Medical School at Harvard University. They are a one-of-a-kind institution on the front lines of the world epidemic of diabetes and are leading the battle to conquer diabetes in all of its forms through cutting-edge research and innovative approaches to clinical care and education. Their vision is a world free of diabetes and its complications and their mission is to prevent, treat, and cure diabetes.

For more information visit: